ORIC Pharmaceuticals Share Price Today: Live Updates & Key Insights
ORIC Pharmaceuticals share price today is $11.16, up 0.54%. The stock opened at $10.92 against the previous close of $11.1, with an intraday high of $11.365 and low of $10.77.
ORIC Pharmaceuticals Share Price Chart
ORIC Pharmaceuticals
ORIC Pharmaceuticals Share Price Performance
ORIC Pharmaceuticals Institutional Holdings
ORIC Pharmaceuticals Market Status
ORIC Pharmaceuticals Fundamentals
Market Cap 1250.00 M
PB Ratio 3.2259
PE Ratio 0.0
Enterprise Value 965.12 M
Total Assets 411.00 M
Volume 3695607
ORIC Pharmaceuticals Company Financials
About ORIC Pharmaceuticals & investment objective
Company Information ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms in cancers in the United States. Its clinical stage product candidates include enozertinib formerly known as ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor, currently under Phase 1b study, that selectively target epidermal growth factor receptor (EGFR) exon 20 and human epidermal growth factor receptor 2 exon 20 with high potency towards exon 20 insertion mutations; and rinzimetostat formerly known as ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer, currently under Phase 1b study. It has a clinical trial collaboration and supply agreement with Bayer to evaluate ORIC-944 in combination with Nubeqa AR inhibitor; and a clinical trial collaboration and supply agreement with Johnson & Johnson to evaluate ORIC 944 in combination with Erleada AR inhibitor. The company was incorporated in 2014 and is headquartered in South San Francisco, California.
Organisation Biotechnology
Employees 104
Industry Biotechnology
CEO Dr. Jacob M. Chacko M.B.A., M.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
ORIC Pharmaceuticals FAQs
What is the share price of ORIC Pharmaceuticals today?
The current share price of ORIC Pharmaceuticals is $11.16.
Can I buy ORIC Pharmaceuticals shares in India?
Yes, Indian investors can buy ORIC Pharmaceuticals shares by opening an international trading and demat account with Motilal Oswal.
How to buy ORIC Pharmaceuticals shares in India?
You can easily invest in ORIC Pharmaceuticals shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy ORIC Pharmaceuticals shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of ORIC Pharmaceuticals.
Can I buy fractional shares of ORIC Pharmaceuticals?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of ORIC Pharmaceuticals?
ORIC Pharmaceuticals has a market cap of $1250.00 M.
In which sector does ORIC Pharmaceuticals belong?
ORIC Pharmaceuticals operates in the Biotechnology sector.
What documents are required to invest in ORIC Pharmaceuticals stocks?
To invest, you typically need:
What is the PE and PB ratio of ORIC Pharmaceuticals?
The PE ratio of ORIC Pharmaceuticals is N/A and the PB ratio is 3.23.